Delivery Order SPE2DB24D2109-SPE2DB25FHWBM

Award Date 12/13/24
Potential Completion Date 12/16/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D2109
    Indefinite Delivery Contract
  • SPE2DB24D2109-SPE2DB25FHWBM
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $1,536.24 to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense.

The award is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC worth $750,000 with the Department of Justice Federal Bureau of Investigation, covering similar medical products and prescription drugs. These strategic IDCs enable efficient government procurement of essential pharmaceutical and medical commodities to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 3/14/25, 9:53 AM